Keerie, A., Brown-Wright, H., Kirkland, I., Grierson, A., Alix, J. J. P., Holscher, C., & Mead, R. J. (2021). The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS. Nature Portfolio.
Style de citation Chicago (17e éd.)Keerie, Amy, Heledd Brown-Wright, Isaac Kirkland, Andrew Grierson, James J. P. Alix, Christian Holscher, et Richard J. Mead. The GLP-1 Receptor Agonist, Liraglutide, Fails to Slow Disease Progression in SOD1G93A and TDP-43Q331K Transgenic Mouse Models of ALS. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Keerie, Amy, et al. The GLP-1 Receptor Agonist, Liraglutide, Fails to Slow Disease Progression in SOD1G93A and TDP-43Q331K Transgenic Mouse Models of ALS. Nature Portfolio, 2021.